Skip to main content
SpringerLink
Log in

Development of analytical technology in pharmacogenetic research

  • Review
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Methods used to determine phenotype and genotype for pharmacogenetic polymorphisms are discussed. Phenotyping is mainly applicable to polymorphisms affecting drug disposition rather than drug response and can involve either direct measurement of enzyme activity or administration of a probe drug followed by measurement of drug and/or metabolite levels. Genotyping is now more widely used than phenotyping and can be used to determine genotype for polymorphisms affecting either drug disposition (for example those in the cytochromes P450 or N-acetyltransferases) or drug response (for example those in drug receptors). Most genotyping for known polymorphisms involves use of the polymerase chain reaction and the wide variety of methods based on this technique that are now used for routine genotyping are discussed in detail. In addition, a range of methods that can be used to detect novel polymorphisms, thereby further increasing understanding of interindividual variability in drug disposition and response, is described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alderborn A, Kristofferson A, Hammerling U (2000) Determination of single-nucleotide polymorphisms by real-time pyrophosphate sequencing. Genome Res 10:1249–1258

    CAS  PubMed  Google Scholar 

  • Alwaiz M, Ayesh R, Mitchell SC, Idle JR, Smith RL (1989) Trimethylaminuria—the detection of carriers using a trimethylamine load test. J Inherit Metab Dis 12:80–85

    CAS  Google Scholar 

  • Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, Gonzalez FJ (1989) Cytochrome P450 hPCN3, a novel cytochrome P450 IIA gene product that is differentially expressed in adult human liver. J Biol Chem 264:10388–10395

    CAS  Google Scholar 

  • Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, Kadlubar FF, Lucier GW (1993) Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14:1689–1694

    CAS  PubMed  Google Scholar 

  • Campbell ME, Spielberg SP, Kalow W (1987) A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 42:157–165

    CAS  PubMed  Google Scholar 

  • Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231–238

    PubMed  Google Scholar 

  • Cascorbi I, Roots I (1999) Pitfalls in N-acetyltransferase 2 genotyping. Pharmacogenetics 9:123–127

    CAS  Google Scholar 

  • Chang M, Dahl ML, Tybring G, Gotharson E, Bertilsson L (1995) Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. Pharmacogenetics 5:358–363

    CAS  PubMed  Google Scholar 

  • Chen SQ, Chou WH, Blouin RA, Mao ZP, Humphries LL, Meek C, Neill JR, Martin WL, Hays LR, Wedlund PJ (1996) The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. Clin Pharmacol Ther 60:522–534

    Google Scholar 

  • Cholerton S, Idle ME, Vas A, Gonzalez FJ, Idle JR (1992) Comparison of a novel thin-layer chromatographic-flourescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. J Chromatogr 575:325–330

    CAS  PubMed  Google Scholar 

  • Cotton RGH (1997) Slowly but surely towards better scanning for mutations. Trends Genet 13:43–46

    CAS  PubMed  Google Scholar 

  • Cribb AE, Isbrucker R, Levatte T, Tsui B, Gillespie CT, Renton KW (1994) Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity. Pharmacogenetics 4:166–170

    CAS  Google Scholar 

  • Daly AK, Steen VM, Fairbrother KS, Idle JR (1996) CYP2D6 multiallelism. Meth Enzymol 272:199–210

    CAS  Google Scholar 

  • Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol 17:153–155

    Google Scholar 

  • Evans DAP, Storey PB, McKusick VA (1960) Genetic control of isoniazid metabolism in man. Br Med J 2:485–491

    Google Scholar 

  • Fuhr U, Rost K (1994) Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and saliva. Pharmacogenetics 4:109–116

    Google Scholar 

  • Gillam EMJ, Guo Z, Ueng Y-F, Yamazaki H, Cock I, Reilly PEB, Hooper WD, Guengerich FP (1995) Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5'modification, purification, reconstitution conditions, and catalytic activities. Arch Biochem Biophys 317:374–384

    Article  CAS  Google Scholar 

  • Grant DM, Tang BK, Kalow W (1983) Polymorphic N-acetylation of a caffeine metabolite. Clin Pharmacol Ther 33:355–359

    CAS  Google Scholar 

  • Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, Yu VL, Grewal R (1997) Human acetyltransferase polymorphisms. Mutat Res 376:61–70

    CAS  PubMed  Google Scholar 

  • Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, VonRichter O, Zundler J, Kroemer HK (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104:147–153

    CAS  PubMed  Google Scholar 

  • Hallier E, Langhof T, Dannappel D, Leutbecher M, Schroder K, Goergens HW, Muller A, Bolt HM (1993) Polymorphism of glutathione conjugation of methyl-bromide, ethylene-oxide and dichloromethane in human blood—influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol 67:173–178

    CAS  PubMed  Google Scholar 

  • Hoffmeyer S, Burk O, vonRichter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97:3473–3478

    CAS  PubMed  Google Scholar 

  • Hongyo T, Buzard GS, Calvert RJ, Weghorst CM (1993) Cold SSCP—a simple, rapid and nonradioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acid Res 21:3637–3642

    CAS  Google Scholar 

  • Howell WM, Jobs M, Gyllensten U, Brookes AJ (1999) Dynamic allele-specific hybridization—a new method for scoring single nucleotide polymorphisms. Nat Biotech 17:87–88

    CAS  PubMed  Google Scholar 

  • Hukkanen J, Hakkola J, Anttila S, Piipari R, Karjalainen A, Pelkonen O, Raunio H (1997) Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450 s in human bronchoalveolar macrophages and peripheral blood lymphocytes. Mol Carcinog 20:224–230

    CAS  PubMed  Google Scholar 

  • Idle JR, Mahgoub A, Angelo MM, Dring LG, Lancaster R, Smith RL (1979) The metabolism of [14C] debrisoquine in man. Br J Clin Pharmacol 7:257–266

    CAS  Google Scholar 

  • Jacqz-Aigrain E, Menard Y, Popon M, Mathieu H (1989) Dextromethorphan phenotypes determined by high-performance liquid chromatography and fluorescence detection. J Chromatogr 495:361–363

    Article  CAS  Google Scholar 

  • Kim RB (2002) MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences. Pharmacogenetics 12:425–427

    Article  CAS  Google Scholar 

  • Kim RB, O'Shea D, Wilkinson GR (1995) Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 57:645–655

    CAS  PubMed  Google Scholar 

  • Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analysed in cryopreserved lymphocytes. Cancer Res 42:5030–5037

    CAS  PubMed  Google Scholar 

  • Leathart JBS, London SJ, Adams JD, Idle JR, Daly AK (1998) CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians. Pharmacogenetics 8:529–542

    CAS  PubMed  Google Scholar 

  • Lennard MS (1985) Quantitative-analysis of metoprolol and 3 of its metabolites in urine and liver-microsomes by high-performance liquid-chromatography. J Chromatogr 342:199–205

    Article  CAS  Google Scholar 

  • Liu ZR, Mortimer O, Smith CAD, Wolf CR, Rane A (1995) Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism. Br J Clin Pharmacol 39:77–80

    CAS  Google Scholar 

  • Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet ii:584–586

    Google Scholar 

  • Milland J, Christiansen D, Thorley BR, McKenzie IFC, Loveland BE (1996) Translation is enhanced after silent nucleotide substitutions in A+T-rich sequences of the coding region of CD46 cDNA. Eur J Biochem 238:221–230

    CAS  Google Scholar 

  • Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T (1999) Genetic polymorphism in the 5 '-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem 125:803–808

    CAS  PubMed  Google Scholar 

  • Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879

    CAS  PubMed  Google Scholar 

  • Patel M, Tang BK, Grant DM, Kalow W (1995) Interindividual variability in the glucuronidation of (S)-oxazepam contrasted with that of (R)-oxazepam. Pharmacogenetics 5:287–297

    CAS  Google Scholar 

  • Playfer JR, Eze LC, Bullen MF, Evans DAP (1976) Genetic polymorphism and inter-ethnic variability of plasma paraoxonase activity. J Med Genet 13:337–342

    CAS  Google Scholar 

  • Price RA, Cox NJ, Spielman RS, Van Loon JA, Maidak BL, Weinshilboum RM (1988) Inheritance of human platelet thermolabile phenol sulphotransferase (TLPST) activity. Genet Epidemiol 5:1–15

    CAS  Google Scholar 

  • Price RA, Spielman RS, Lucena AL, Van Loon JA, Maidak BL, Weinshilboum RM (1989) Genetic polymorphism for human platelet thermostable phenol sulphotransferase (TSPST) activity. Genetics 122:905–914

    CAS  Google Scholar 

  • Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL, Carpenter SP (1997) Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 25:1429–1435

    CAS  PubMed  Google Scholar 

  • Ravnik-Glavac M, Glavac D, Dean M (1994) Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic-fibrosis gene. Hum Mol Genet 3:801–807

    PubMed  Google Scholar 

  • Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB (1998) Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 90:1225–1229

    CAS  PubMed  Google Scholar 

  • Sachse C, Brockmoller J, Bauer S, Roots I (1997) Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 60:284–295

    Google Scholar 

  • Sachse C, Brochmoller J, Bauer S, Roots I (1999) Functional significance of a C→A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47:445–449

    Article  CAS  PubMed  Google Scholar 

  • Sachse C, Bhambra U, Smith G, Lightfoot TJ, Barrett JH, Scollay J, Garner RC, Boobis AR, Wolf CR, Gooderham NJ (2003) Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 55:68–76

    Article  CAS  PubMed  Google Scholar 

  • Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ (2000) CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity. Clin Pharmacol Ther 67:48–56

    CAS  PubMed  Google Scholar 

  • Seidegard J, Pero RW (1985) The hereditary transmission of high glutathione transferase-activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum Genet 69:66–68

    CAS  Google Scholar 

  • Shimoda K, Noguchi T, Ozeki Y, Morita S, Shibasaki M, Someya T, Takahashi S (1995) Metabolism of clomipramine in a Japanese psychiatric population—hydroxylation, desmethylation, and glucuronidation. Neuropsychopharmacology 12:323–333

    CAS  Google Scholar 

  • Sinues B, Saenz MA, Lanuza J, Bernal ML, Fanlo A, Juste JL, Mayayo E (1999) Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow. Cancer Epidemiol Biomarkers Prev 8:159–166

    CAS  Google Scholar 

  • Streetman DS, Bertino JS, Nafziger AN (2000) Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo phenotyping probes. Pharmacogenetics 10:187–216

    CAS  PubMed  Google Scholar 

  • Syvanen AC (1999) From gels to chips: ''minisequencing'' primer extension for analysis of point mutations and single nucleotide polymorphisms. Hum Mutat 13:1–10

    CAS  PubMed  Google Scholar 

  • Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Hartwell PS, Raisys VA, Marsh CL, McVicar JP, Barr DM, Perkins JD, Carithers RL (1994) Use of midazolam as a human cytochrome-P450 3a probe. I. In-vitro in-vivo correlation in liver-transplant patients. J Pharmacol Exp Ther 271:549–556

    Google Scholar 

  • Veronese ME, Miners JO, Randles D, Gregov D, Birkett DJ (1990) Validation of the tolbutamide metabolic ratio for population screening with the use of sulfaphenazole to produce model phenotypic poor metabolizers. Clin Pharmacol Ther 47:403–411

    Google Scholar 

  • Watkins PB, Hamilton TA, Annesley TM, Ellis CN, Kolars JC, Voorhees JJ (1990) The erythromycin breath test as a predictor of cyclosporine blood-levels. Clin Pharmacol Ther 48:120–129

    CAS  Google Scholar 

  • Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA (1984) Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism. Clin Pharmacol Ther 36:773–780

    CAS  Google Scholar 

  • Weinshilboum RM, Raymond FA (1977) Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am J Hum Genet 29:125–135

    CAS  Google Scholar 

  • Weinshilboum R, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651–662

    CAS  PubMed  Google Scholar 

  • Westlind A, Lofberg L, Tindberg N, Andersson TB, Ingelman Sundberg M (1999) Interindividual differences in hepatic expression of CYP3A4: Relationship to genetic polymorphism in the 5'-upstream regulatory region. Biochem Biophys Res Comm 259:201–205

    CAS  PubMed  Google Scholar 

  • Whittaker M, Britten JJ, Dawson PJG (1983) Comparison of a commercially available assay system with two reference methods for the determination of cholinesterase variants. Clin Chem 29:1746–1751

    CAS  Google Scholar 

  • Xiao W, Oefner PJ (2001) Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439–474

    Article  CAS  Google Scholar 

  • Yue QY, Iselius L, Sawe J (1997) Indices and graphical approaches for the detection of interindividual and interethnic variations in codeine metabolism. Br J Clin Pharmacol 44:239–244

    CAS  Google Scholar 

  • Zhiri A, Mayer HA, Michaux V, Wellmanbednawska M, Siest G (1986) 6-Beta-hydroxycortisol in serum and urine as determined by enzyme-immunoassay on microtitre plates. Clin Chem 32:2094–2097

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacogenetics Group, School of Clinical and Laboratory Sciences, Medical School, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK

    Ann K. Daly

Authors
  1. Ann K. Daly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ann K. Daly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daly, A.K. Development of analytical technology in pharmacogenetic research. Naunyn-Schmiedeberg's Arch Pharmacol 369, 133–140 (2004). https://doi.org/10.1007/s00210-003-0794-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-003-0794-4

Keywords

Search

Navigation